Protein Interactions as Targets in Drug Discovery - 1st Edition - ISBN: 9780128168462

Protein Interactions as Targets in Drug Discovery, Volume 122

1st Edition

Editors: Rossen Donev
Hardcover ISBN: 9780128168462
Imprint: Academic Press
Published Date: 1st May 2020
Page Count: 264
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Latest trends in structure based drug design with protein targets
Angshuman Bagchi
2. From fragment- to peptide-protein interaction: addressing the structural basis of binding using Supervised Molecular Dynamics (SuMD)
Stefano Moro
3. Protein-protein and protein-ligand interactions: identification of potential inhibitors through computational analysis
M. Michael Gromiha
4. Aromatic-aromatic interactions in protein-drug and protein-protein interactions
Adrian Gustavo Turjanski
5. Role of protein-protein interaction in allosteric drug design within the human methyltransferome
Guang Hu
6. Protein-Protein Interactions as the Basis for Cyclin-Dependent Kinase Inhibition
Mark Klein
7. Targeting FOXP3 complex ensemble in drug discovery
Bin Li
8. Targeting arrestin interactions with its partners for therapeutic purposes
Vsevolod V. Gurevich
9. Protein interactomics in kidney stone research
Visith Thongboonkerd
10. Human oral microbiome protein-protein interaction a cross-talk with health systemic implications
Marlene M.T. Barros
11. Protein-protein complexes as targets for drug discovery against infectious diseases
Yusuf Akhter
12. Therapeutic intervention of protein-protein interactions in innate immunity
Kevin J. Lumb
13. Physicochemical determinants of antibody-protein interactions
Sibel Kalyoncu Uzunlar


Description

Protein Interactions as Targets in Drug Discovery, Volume 122 is dedicated to the design of therapeutics, both experimental and computational, that target protein interactions. Chapters in this new release include Trends in structure based drug design with protein targets, From fragment- to peptide-protein interaction: addressing the structural basis of binding using Supervised Molecular Dynamics (SuMD), Protein-protein and protein-ligand interactions: identification of potential inhibitors through computational analysis, Aromatic-aromatic interactions in protein-drug and protein-protein interactions, Role of protein-protein interaction in allosteric drug design within the human methyltransferome, and much more.

Key Features

  • Integrates experimental and computational methods for studying protein interactions and their modulation by potential therapeutics
  • Contains timely chapters written by well-renown authorities in their field
  • Covers information that is well supported by a number of high quality illustrations, figures and tables
  • Targets a very wide audience of specialists, researchers and students

Readership

This volume would be of great interest to a very wide audience - protein chemists, molecular cell biologists, immunologists, structural biologists, computational biochemists, medical doctors, pharmacologists and other researchers working in the field of protein interactions. Articles published here would also be of a considerable benefit to medical, biology and pharmacology students specializing in this field


Details

No. of pages:
264
Language:
English
Copyright:
© Academic Press 2020
Published:
1st May 2020
Imprint:
Academic Press
Hardcover ISBN:
9780128168462

Ratings and Reviews


About the Editors

Rossen Donev

Rossen Donev Editor

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on design of antibody-based oral treatment of pathological conditions of the gastrointestinal tract.

Affiliations and Expertise

Swansea University, UK